Zajac Ian T, Duncan Amy C, Flight Ingrid, Wittert Gary A, Cole Stephen R, Young Graeme P, Wilson Carlene J, Turnbull Deborah A
CSIRO Health & Biosecurity, South Australia, Australia.
School of Psychology, University of Adelaide, South Australia, Australia.
Soc Sci Med. 2016 Sep;165:1-9. doi: 10.1016/j.socscimed.2016.06.036. Epub 2016 Jul 1.
Male participation in screening for bowel cancer is sub-optimal. Theory-based interventions provide a means of improving screening uptake.
To test the efficacy of modifying consumer invitation material in line with continuum and stage theories of health behaviour on screening participation.
N = 9216 Australian men aged 50-74 years were randomised to one of four trial arms in a 2 × 2 factorial design randomised controlled trial. Participants received either standard invitation material (control group), or combinations of modified advance-notification and invitation letters. A subsample completed baseline and endpoint behavioural surveys.
Participants who received the modified advance notification letter were 12% more likely to screen than those who received the standard version (RR = 1.12, χ(2)(1) = 10.38, p = 0.001). The modified invitation letter did not impact screening uptake (RR = 0.97, χ(2)(1) = 0.63, p = 0.424). No significant changes in psychological variables due to the intervention were observed.
Modifications to advance notification letters in line with health behaviour theories significantly improves screening uptake in men.
Australian New Zealand Clinical Trials Registry: ACTRN12612001122842 https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=362688.
男性参与肠癌筛查的情况并不理想。基于理论的干预措施提供了一种提高筛查参与率的方法。
根据健康行为的连续体理论和阶段理论,测试修改面向消费者的邀请材料对筛查参与情况的效果。
在一项2×2析因设计的随机对照试验中,将9216名年龄在50 - 74岁的澳大利亚男性随机分为四个试验组之一。参与者收到的要么是标准邀请材料(对照组),要么是修改后的提前通知信和邀请信的组合。一个子样本完成了基线和终点行为调查。
收到修改后的提前通知信的参与者进行筛查的可能性比收到标准版本的参与者高12%(相对风险RR = 1.12,χ(2)(1)=10.38,p = 0.001)。修改后的邀请信对筛查参与率没有影响(RR = 0.97,χ(2)(1)=0.63,p = 0.424)。未观察到因干预导致的心理变量有显著变化。
根据健康行为理论修改提前通知信可显著提高男性的筛查参与率。
澳大利亚新西兰临床试验注册中心:ACTRN12612001122842 https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=362688